Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.540
-0.400 (-20.62%)
At close: Jul 15, 2025, 4:00 PM
1.680
+0.140 (9.09%)
After-hours: Jul 15, 2025, 5:15 PM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $110.19 million as of July 15, 2025. Its market cap has increased by 45.80% in one year.
Market Cap
110.19M
Enterprise Value
127.23M
1-Year Change
45.80%
Ranking
Category
Stock Price
1.54
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has increased from $90.21M to $110.19M, an increase of 22.14%. That is a compound annual growth rate of 8.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 138.81M | 68.70% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |